412 related articles for article (PubMed ID: 33683246)
1. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19.
Barh D; Tiwari S; Andrade BS; Weener ME; Góes-Neto A; Azevedo V; Ghosh P; Blum K; Ganguly NK
Mol Omics; 2021 Apr; 17(2):317-337. PubMed ID: 33683246
[TBL] [Abstract][Full Text] [Related]
2. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.
Silva Andrade B; Siqueira S; de Assis Soares WR; de Souza Rangel F; Santos NO; Dos Santos Freitas A; Ribeiro da Silveira P; Tiwari S; Alzahrani KJ; Góes-Neto A; Azevedo V; Ghosh P; Barh D
Viruses; 2021 Apr; 13(4):. PubMed ID: 33919537
[TBL] [Abstract][Full Text] [Related]
3. Post-acute sequelae of SARS-CoV-2 infection: Caring for the 'long-haulers'.
Vehar S; Boushra M; Ntiamoah P; Biehl M
Cleve Clin J Med; 2021 May; 88(5):267-272. PubMed ID: 33941600
[TBL] [Abstract][Full Text] [Related]
4. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.
Barh D; Aljabali AA; Tambuwala MM; Tiwari S; Serrano-Aroca Á; Alzahrani KJ; Silva Andrade B; Azevedo V; Ganguly NK; Lundstrom K
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067609
[TBL] [Abstract][Full Text] [Related]
5. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis.
Yong SJ
ACS Chem Neurosci; 2021 Feb; 12(4):573-580. PubMed ID: 33538586
[TBL] [Abstract][Full Text] [Related]
6. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
Stefano GB
Med Sci Monit; 2021 Feb; 27():e931447. PubMed ID: 33633106
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: from an acute to chronic disease? Potential long-term health consequences.
Higgins V; Sohaei D; Diamandis EP; Prassas I
Crit Rev Clin Lab Sci; 2021 Aug; 58(5):297-310. PubMed ID: 33347790
[TBL] [Abstract][Full Text] [Related]
8. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
[TBL] [Abstract][Full Text] [Related]
9. Return-to-work, disabilities and occupational health in the age of COVID-19.
Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
[TBL] [Abstract][Full Text] [Related]
11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
12. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care.
Parums DV
Med Sci Monit; 2021 Jun; 27():e933446. PubMed ID: 34092779
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of cancer patients with COVID-19.
Yang F; Shi S; Zhu J; Shi J; Dai K; Chen X
J Med Virol; 2020 Oct; 92(10):2067-2073. PubMed ID: 32369209
[TBL] [Abstract][Full Text] [Related]
15. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.
Stefano GB; Ptacek R; Ptackova H; Martin A; Kream RM
Med Sci Monit; 2021 Jan; 27():e930886. PubMed ID: 33487628
[TBL] [Abstract][Full Text] [Related]
16. Health Conditions Associated With Severe Illness From COVID-19 Among Individuals With Serious Mental Illness.
Novak P; Sanmartin MX; Ali MM; Chen J
Psychiatr Serv; 2021 Apr; 72(4):468-469. PubMed ID: 33208029
[No Abstract] [Full Text] [Related]
17. [Long lasting symptoms of dyspnea, cough and fatigue after COVID-19 - narrative review of epidemiological studies].
Marciniak E; Górniak A; Hanke W
Med Pr; 2021 Dec; 72(6):711-720. PubMed ID: 34850782
[TBL] [Abstract][Full Text] [Related]
18. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19.
Zhu Z; Zhang S; Wang P; Chen X; Bi J; Cheng L; Zhang X
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34718395
[TBL] [Abstract][Full Text] [Related]
20. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
Yamamoto N; Yamamoto R; Ariumi Y; Mizokami M; Shimotohno K; Yoshikura H
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
